Emory University’s School of Medicine is embarking on a groundbreaking new initiative to develop a drug discovery pipeline for translating fundamental biological discoveries into the next generation of life-saving treatments. The idea for the center was formulated by esteemed co-directors Haian Fu, PhD, professor and chair of the Department of Pharmacology and Chemical Biology in the Emory School of Medicine, and chemist Dennis Liotta, PhD, co-founder and former executive director of Drug Innovation Ventures at Emory (DRIVE) and the Emory Institute for Drug Development, along with a leadership team with a shared vision.
Tag: Dennis Liotta
Throughout his multi-decade career, Dennis Liotta has been instrumental in the creation of novel therapies that have benefited millions of lives around the world. Continue readingDennis Liotta honored at White House for innovation in HIV treatment
Dennis Liotta featured in report that celebrates people behind life-changing inventions fostered by the Bayh-Dole Act.Continue readingDennis Liotta profiled in “Faces of American Innovation” Report
Graduate scholar Hannah Gold has received the 2022 Society of Chemical Industry Perkin Medal Scholarship. Continue readingHannah Gold receives 2022 Society of Chemical Industry Perkin Medal Scholarship
Categories
Molnupiravir and Drug Development at Emory
Molnupiravir is currently being developed by Merck & Co. Inc. in collaboration with Ridgeback Biotherapeutics, which licensed the drug from DRIVE (founded by Emory chemist Dennis Liotta) in 2020. It could be the first oral antiviral medicine to treat COVID-19. Continue readingMolnupiravir and Drug Development at Emory
DRIVE seeks disease-fighting solutions via a different paradigm than big pharmaceutical industry. The New York Times features an opinion piece titled “In the Race for a Covid-19 Pill, a Little Lab Plays a Big Role.”Continue readingLiotta Group and DRIVE featured in New York Times
Graduate alum Kimberlynn Davis (Liotta Group) shares her career journey in biopharma complete with the twists and surprises on the road to achieve her goals, imperfectly.Continue readingGraduate alum Kimberlynn Davis co-founder of Sidebars podcast
Categories
What is a research statement?
Faculty 411 is a series of articles intended to help demystify the process of applying to faculty jobs. As our department seeks to recruit new faculty colleagues, we want every person to have the information they need to assemble an application that best shows their potential to be successful in a job – at Emory or anywhere!Continue readingWhat is a research statement?
Categories
Chemistry responds to COVID-19
“International work is part of the fabric of Emory University. Our world-class faculty, internationally engaged staff and community of highly talented international students, scholars and alumni develop initiatives and collaborations that have global scope, and the International Awards were established to celebrate these exemplary people as they further Emory’s impact around the world.” Read the…Continue readingDennis Liotta among Emory researchers recognized for global impact
“Achieving efficient delivery of a neuroprotectant into the brain is crucial for acute intervention in neural injury,” said Dennis Liotta, Director, Emory Institute for Drug Development and Samuel Candler Dobbs Professor, Department of Chemistry. “These novel compounds may penetrate the blood brain barrier and, with further testing, could become attractive candidates used to treat stroke and TBI patients.” Read…Continue readingNeuroTrauma Sciences Enters Into Worldwide License Agreement with Emory University for Molecules to Treat Stroke and Traumatic Brain Injury